EUDA Health (EUDA) Projected to Post Quarterly Earnings on Wednesday

EUDA Health (NASDAQ:EUDA) is expected to post its results before the market opens on Wednesday, February 25th. Analysts expect EUDA Health to post earnings of $0.02 per share and revenue of $6.3630 million for the quarter.

EUDA Health Price Performance

EUDA opened at $0.90 on Friday. EUDA Health has a 1 year low of $0.71 and a 1 year high of $4.30. The company has a market capitalization of $34.12 million, a price-to-earnings ratio of -7.52 and a beta of -0.15. The firm’s fifty day moving average price is $1.74 and its two-hundred day moving average price is $2.17.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of EUDA Health in a research report on Friday, January 9th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, EUDA Health has a consensus rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently raised its position in EUDA Health stock. Citadel Advisors LLC grew its position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,631 shares of the company’s stock after purchasing an additional 16,321 shares during the period. Citadel Advisors LLC owned approximately 0.12% of EUDA Health worth $78,000 at the end of the most recent quarter. Institutional investors and hedge funds own 4.35% of the company’s stock.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.